Strota/ Newsroom/ 2026-07-09

GKSL (GKSL): Acquisition / M&A

Strota Newsroom · session of 2026-07-09 · 09 Jul 21:13 · GKSL stock page →

Gujarat Kidney And Super Speciality Limited has informed the Exchange about Acquisition of 51% of Blue Tree Clinics LLC Historically, acquisition / m&a events have moved GKSL-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Gujarat Kidney And Super Speciality Limited has informed the Exchange about the acquisition of 51% of Blue Tree Clinics LLC, according to an NSE filing dated 9 July. The company, which trades under the symbol GKSL, has a market capitalisation of ₹1,033 crore.

Events like this—acquisitions or M&A announcements—have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213%. This base rate reflects how similar corporate events have performed on average in the past, not a forecast for this specific stock.

The stock currently trades at a price-to-earnings ratio of 52.6 and a price-to-book ratio of 3.23, with return on equity at 11.9% and earnings per share of ₹2.49. The Nifty moved 0.34% on the session.

The filing confirms the transaction has occurred. It does not establish the financial terms of the deal, Blue Tree Clinics' revenue or profitability, or how the acquisition will be funded. The historical base rate for this event type is mixed, with wins slightly below the loss rate.

The catalyst

Gujarat Kidney And Super Speciality Limited has informed the Exchange about Acquisition of 51% of Blue Tree Clinics LLC (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

GKSL right now

P/E 52.6. Full GKSL analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.